Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain
NCT02367820
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
638
Enrollment
INDUSTRY
Sponsor class
Conditions
Low Back Pain
Chronic Pain
Interventions
DRUG:
NKTR-181 BID tablets
Sponsor
Nektar Therapeutics